Search results
Bears are Losing Control Over Aprea Therapeutics, Inc. (APRE), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 1 year agoAprea Therapeutics, Inc. (APRE) appears to have found support after losing some value lately, as...
Aprea (APRE) Rises on Advancing Lead Drug to Clinical Studies
Zacks via Yahoo Finance· 1 year agoShares of Aprea Therapeutics APRE were up 12% on Jan 11 after management announced that it dosed the...
Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 4 months agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
This $25 Rare Beauty Rose Lip Oil & Liner Duo Is on Their Holiday Wish List
Good Housekeeping via Yahoo News· 5 months agoTake the pressure off gifting this season with our roundup of beauty sets. We've got the deals on...
Jazz Pharma (JAZZ) Gets EU Nod for Cancer Drug Enrylaze
Zacks via Yahoo Finance· 7 months agoThe approval is based on data from a phase II/III study, which showed that treatment with Jazz's...